Para-cycling

Paralyzed Veterans of America Seventh Annual Wheelchair Rugby Invitational Crowns Code of Honor Cup Winners, Promotes Adaptive Sports In Louisville

Retrieved on: 
Tuesday, January 16, 2024

LOUISVILLE, Ky., Jan. 16, 2024 /PRNewswire/ -- Paralyzed Veterans of America today concluded their seventh annual Wheelchair Rugby Invitational in Louisville, Kentucky, presenting the Code of Honor Cup to the winners of each division.

Key Points: 
  • LOUISVILLE, Ky., Jan. 16, 2024 /PRNewswire/ -- Paralyzed Veterans of America today concluded their seventh annual Wheelchair Rugby Invitational in Louisville, Kentucky, presenting the Code of Honor Cup to the winners of each division.
  • The invitational kicked off with an all-veteran scrimmage on Thursday, January 11 and a variety of awards were presented at the end of the invitational.
  • PVA could not be more proud to host this annual event and advocate for the importance of adaptive sports for people with disabilities."
  • Since 2018, PVA has hosted the Wheelchair Rugby Invitational to broaden the scope of its sports program, to grow the sport of wheelchair rugby and to empower the disability community.

Paralyzed Veterans of America's new virtual program brings whole-self wellness to America's catastrophically injured veterans

Retrieved on: 
Tuesday, January 31, 2023

Launching on January 31, PVA's Sports and Recreation Department's Health and Wellness program will begin hosting a variety of virtual, six-week classes focusing on everything from movement to mindfulness.

Key Points: 
  • Launching on January 31, PVA's Sports and Recreation Department's Health and Wellness program will begin hosting a variety of virtual, six-week classes focusing on everything from movement to mindfulness.
  • "What's more, our online platform will increase accessibility and cultivate a community of encouragement and support for the disability community."
  • PVA's Health and Wellness program will host its first three courses in its Winter series – two of which are designed solely for women.
  • Each class is free and open to paralyzed veterans, their families and caregivers, as well as all people with disabilities.

Challenged Athletes Foundation Grant Recipients Shine at the Tokyo 2020 Paralympic Games

Retrieved on: 
Friday, September 10, 2021

SAN DIEGO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- After two weeks of competition among the worlds top athletes with physical disabilities, the Challenged Athletes Foundation (CAF) celebrates the power of the human spirit that was showcased during the Tokyo 2020 Paralympic Games.

Key Points: 
  • SAN DIEGO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- After two weeks of competition among the worlds top athletes with physical disabilities, the Challenged Athletes Foundation (CAF) celebrates the power of the human spirit that was showcased during the Tokyo 2020 Paralympic Games.
  • CAF is honored to play an integral part in their journey and we remain dedicated in developing the next generation of Paralympic athletes.
  • Bethany Zummo and the Team USA Women's Sitting Volleyball team also took home the gold after defeating China in the final match to repeat as Paralympic champions.
  • For a complete Media Guide of CAF Paralympic athletes with bios, images and video please click here: CAF Paralympic Press Kit
    The Challenged Athletes Foundation (CAF) is a world leader in helping people with physical challenges lead active, healthy lifestyles.

T2 Biosystems to Report Second Quarter 2021 Financial Results on August 5, 2021

Retrieved on: 
Thursday, July 22, 2021

LEXINGTON, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2021 after market close onThursday, August 5, 2021.

Key Points: 
  • LEXINGTON, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2021 after market close onThursday, August 5, 2021.
  • Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time.
  • The call will also be available by dialing 1-877-407-9208 (U.S.) or 1-201-493-6784 (International) five to ten minutes prior to the start time.
  • T2 Biosystems products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology.

T2 Biosystems to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

Retrieved on: 
Tuesday, February 23, 2021

LEXINGTON, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2020 after market close onThursday, March 4, 2021.

Key Points: 
  • LEXINGTON, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2020 after market close onThursday, March 4, 2021.
  • Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time.
  • The call will also be available by dialing 877-407-9208 (U.S.) or 201-493-6784 (International) five to ten minutes prior to the start time.
  • T2 Biosystems products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology.

T2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020

Retrieved on: 
Tuesday, July 28, 2020

LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close onTuesday, August 11, 2020.

Key Points: 
  • LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close onTuesday, August 11, 2020.
  • Company management will host a corresponding conference call beginning at4:30 p.m. Eastern Time.
  • The call will also be available by dialing 877-407-9208 (U.S.) or 201-493-6784 (International) five to ten minutes prior to the start time.
  • T2 Biosystems products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology.

Never Be Lost In Translation Again: Timekettle's Revolutionary World First Offline Translation Feature for WT2 Plus Translator Earbud Redefines International Communication

Retrieved on: 
Friday, July 3, 2020

LOS ANGELES, July3, 2020 /PRNewswire/ -- The team at Timekettle is proud to announce the launch of an offline translation feature, the latest software upgrade to its flagship device, Timekettle WT2 Plus translator earbuds .

Key Points: 
  • LOS ANGELES, July3, 2020 /PRNewswire/ -- The team at Timekettle is proud to announce the launch of an offline translation feature, the latest software upgrade to its flagship device, Timekettle WT2 Plus translator earbuds .
  • The innovative new feature is a world first, currently offering seamless in-ear translation between Chinese, French, Japanese, Russian, and Spanish, and English without the need for an internet connection.
  • With the WT2 Plus' new offline capabilities, Timekettle has opened a whole new world of limitless communication," said Leal Tian, CEO of Timekettle.
  • The offline translation feature marks the latest improvement in a series of upgrades in the past six months.

Hackensack Meridian Health's Center for Discovery and Innovation COVID-19 Test Licensed to T2 Biosystems for Widespread Deployment

Retrieved on: 
Tuesday, March 24, 2020

The wider deployment of the COVID-19 test, already in use in the Hackensack Meridian Health network, will meet a crucial need amid the continuing spread of the novel coronavirus.

Key Points: 
  • The wider deployment of the COVID-19 test, already in use in the Hackensack Meridian Health network, will meet a crucial need amid the continuing spread of the novel coronavirus.
  • Under this agreement, T2 Biosystems is authorized to adapt the CDI-developed COVID-19 test to the T2 Biosystems platform, and market and distribute the test in places of need amid the expanding pandemic.
  • The test will be capable of running on the T2Dx Instrument, the same instrument which runs the FDA-cleared T2Bacteria and T2Candida Panels.
  • T2 Biosystems' products include the T2Dx Instrument, T2Candida Panel, the T2Bacteria Panel, and the T2Resistance Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology.